Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligonucleotides, Antisense | 18 | 2025 | 134 | 7.010 |
Why?
|
| Oligonucleotides | 20 | 2025 | 210 | 4.550 |
Why?
|
| RNA, Small Interfering | 14 | 2024 | 857 | 3.130 |
Why?
|
| Gene Silencing | 11 | 2024 | 380 | 2.310 |
Why?
|
| Gene Editing | 10 | 2024 | 301 | 2.300 |
Why?
|
| RNA | 10 | 2024 | 405 | 1.600 |
Why?
|
| Nucleic Acids | 2 | 2022 | 50 | 1.360 |
Why?
|
| RNA Interference | 8 | 2024 | 593 | 1.150 |
Why?
|
| RNA, Double-Stranded | 6 | 2020 | 108 | 1.070 |
Why?
|
| CRISPR-Cas Systems | 5 | 2024 | 332 | 1.050 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 306 | 1.020 |
Why?
|
| Glioblastoma | 2 | 2024 | 156 | 1.000 |
Why?
|
| Fibroblasts | 4 | 2022 | 378 | 0.910 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2024 | 183 | 0.910 |
Why?
|
| Friedreich Ataxia | 2 | 2022 | 4 | 0.870 |
Why?
|
| Genetic Therapy | 5 | 2025 | 743 | 0.850 |
Why?
|
| DNA | 10 | 2024 | 810 | 0.840 |
Why?
|
| RNA, Long Noncoding | 3 | 2024 | 151 | 0.830 |
Why?
|
| Splints | 1 | 2021 | 5 | 0.780 |
Why?
|
| Arabinonucleotides | 3 | 2010 | 4 | 0.750 |
Why?
|
| RNA, Messenger | 5 | 2022 | 1474 | 0.750 |
Why?
|
| Gene Expression Regulation | 6 | 2022 | 1549 | 0.740 |
Why?
|
| Endothelial Cells | 1 | 2022 | 178 | 0.720 |
Why?
|
| Mice | 16 | 2024 | 10338 | 0.710 |
Why?
|
| Phenotype | 1 | 2024 | 1157 | 0.710 |
Why?
|
| Animals | 24 | 2024 | 19802 | 0.680 |
Why?
|
| Proprotein Convertase 9 | 1 | 2020 | 12 | 0.670 |
Why?
|
| Acetylgalactosamine | 2 | 2024 | 10 | 0.670 |
Why?
|
| Peptide Nucleic Acids | 2 | 2018 | 17 | 0.650 |
Why?
|
| Lung | 3 | 2023 | 904 | 0.630 |
Why?
|
| Drug Delivery Systems | 4 | 2022 | 312 | 0.630 |
Why?
|
| Triazoles | 2 | 2018 | 52 | 0.600 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 105 | 0.570 |
Why?
|
| RNAi Therapeutics | 1 | 2017 | 12 | 0.560 |
Why?
|
| Humans | 38 | 2025 | 60913 | 0.540 |
Why?
|
| Monosaccharides | 2 | 2007 | 7 | 0.540 |
Why?
|
| Uridine | 2 | 2007 | 16 | 0.540 |
Why?
|
| Cells, Cultured | 5 | 2022 | 2106 | 0.460 |
Why?
|
| Antiviral Agents | 2 | 2023 | 318 | 0.450 |
Why?
|
| Phosphorothioate Oligonucleotides | 2 | 2024 | 10 | 0.430 |
Why?
|
| Organophosphorus Compounds | 3 | 2023 | 32 | 0.430 |
Why?
|
| Cytidine Deaminase | 2 | 2025 | 84 | 0.420 |
Why?
|
| Central Nervous System | 2 | 2024 | 192 | 0.400 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 846 | 0.390 |
Why?
|
| Iron-Binding Proteins | 2 | 2022 | 8 | 0.360 |
Why?
|
| Thermodynamics | 2 | 2010 | 198 | 0.350 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 1389 | 0.340 |
Why?
|
| RNA, Antisense | 1 | 2010 | 49 | 0.340 |
Why?
|
| Liver | 4 | 2024 | 800 | 0.330 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 192 | 0.320 |
Why?
|
| Organoselenium Compounds | 1 | 2008 | 4 | 0.310 |
Why?
|
| Oligoribonucleotides | 1 | 2008 | 14 | 0.300 |
Why?
|
| Aptamers, Nucleotide | 2 | 2021 | 18 | 0.300 |
Why?
|
| Genome, Human | 2 | 2021 | 222 | 0.290 |
Why?
|
| Enzyme Inhibitors | 2 | 2025 | 354 | 0.290 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 664 | 0.280 |
Why?
|
| Precision Medicine | 2 | 2025 | 107 | 0.270 |
Why?
|
| Nanoparticles | 3 | 2021 | 496 | 0.250 |
Why?
|
| Base Sequence | 7 | 2022 | 1310 | 0.250 |
Why?
|
| Rare Diseases | 1 | 2025 | 38 | 0.240 |
Why?
|
| Models, Molecular | 4 | 2021 | 1140 | 0.240 |
Why?
|
| Trinucleotide Repeat Expansion | 3 | 2023 | 32 | 0.240 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2024 | 20 | 0.230 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.230 |
Why?
|
| Molecular Conformation | 3 | 2017 | 135 | 0.230 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2024 | 34 | 0.230 |
Why?
|
| Ribonuclease H | 2 | 2018 | 18 | 0.230 |
Why?
|
| C9orf72 Protein | 2 | 2022 | 104 | 0.230 |
Why?
|
| DNA, Single-Stranded | 2 | 2022 | 100 | 0.220 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2024 | 102 | 0.220 |
Why?
|
| RNA Splicing | 2 | 2022 | 160 | 0.220 |
Why?
|
| Information Dissemination | 1 | 2025 | 119 | 0.220 |
Why?
|
| Mice, Nude | 1 | 2024 | 260 | 0.220 |
Why?
|
| Adenine | 1 | 2024 | 47 | 0.220 |
Why?
|
| Technology | 1 | 2023 | 50 | 0.220 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2023 | 15 | 0.220 |
Why?
|
| Endonucleases | 1 | 2023 | 81 | 0.210 |
Why?
|
| Drug Design | 2 | 2017 | 143 | 0.210 |
Why?
|
| Fragile X Syndrome | 1 | 2023 | 27 | 0.210 |
Why?
|
| DNA Repair | 2 | 2021 | 244 | 0.210 |
Why?
|
| Neoplastic Stem Cells | 1 | 2024 | 203 | 0.210 |
Why?
|
| Trachea | 1 | 2022 | 92 | 0.200 |
Why?
|
| Motor Activity | 1 | 2024 | 345 | 0.190 |
Why?
|
| Trypsin | 1 | 2021 | 39 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 193 | 0.180 |
Why?
|
| Endoribonucleases | 1 | 2021 | 53 | 0.180 |
Why?
|
| Cells | 1 | 2021 | 31 | 0.180 |
Why?
|
| Chromatids | 1 | 2020 | 15 | 0.180 |
Why?
|
| Chromosome Segregation | 1 | 2020 | 39 | 0.180 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2021 | 113 | 0.170 |
Why?
|
| Frontotemporal Dementia | 1 | 2022 | 136 | 0.170 |
Why?
|
| Germany | 1 | 2019 | 53 | 0.170 |
Why?
|
| Circular Dichroism | 3 | 2010 | 108 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1303 | 0.160 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 2080 | 0.150 |
Why?
|
| Solid-Phase Synthesis Techniques | 1 | 2018 | 3 | 0.150 |
Why?
|
| Zebrafish | 1 | 2021 | 324 | 0.150 |
Why?
|
| Water | 2 | 2010 | 303 | 0.150 |
Why?
|
| Transcription Factor 4 | 1 | 2018 | 2 | 0.150 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2018 | 3 | 0.150 |
Why?
|
| Macromolecular Substances | 1 | 2018 | 160 | 0.150 |
Why?
|
| Chromatin | 2 | 2020 | 603 | 0.140 |
Why?
|
| Mutation | 2 | 2024 | 2485 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2022 | 484 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 168 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2018 | 196 | 0.140 |
Why?
|
| Nucleosides | 2 | 2007 | 11 | 0.130 |
Why?
|
| Escherichia coli | 1 | 2021 | 693 | 0.130 |
Why?
|
| DNA-Binding Proteins | 1 | 2022 | 1151 | 0.130 |
Why?
|
| Molecular Targeted Therapy | 1 | 2017 | 120 | 0.130 |
Why?
|
| Nucleic Acid Conformation | 3 | 2020 | 234 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2016 | 65 | 0.130 |
Why?
|
| ADAM Proteins | 1 | 2016 | 35 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 278 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2018 | 494 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 747 | 0.120 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 628 | 0.120 |
Why?
|
| Molecular Imprinting | 1 | 2014 | 4 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 895 | 0.120 |
Why?
|
| Alleles | 2 | 2018 | 424 | 0.110 |
Why?
|
| RNA Polymerase II | 2 | 2014 | 72 | 0.110 |
Why?
|
| Hepacivirus | 1 | 2015 | 140 | 0.110 |
Why?
|
| Nucleic Acid Denaturation | 2 | 2010 | 7 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2014 | 256 | 0.110 |
Why?
|
| Cations | 2 | 2011 | 63 | 0.110 |
Why?
|
| Catalytic Domain | 2 | 2025 | 194 | 0.100 |
Why?
|
| Hydrogen Bonding | 2 | 2010 | 125 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2024 | 623 | 0.100 |
Why?
|
| Molecular Structure | 2 | 2011 | 380 | 0.090 |
Why?
|
| Spermine | 1 | 2011 | 2 | 0.090 |
Why?
|
| Polymers | 1 | 2014 | 318 | 0.090 |
Why?
|
| Alternative Splicing | 1 | 2011 | 124 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2018 | 1486 | 0.090 |
Why?
|
| Male | 4 | 2024 | 28424 | 0.090 |
Why?
|
| Fluorine | 1 | 2010 | 9 | 0.090 |
Why?
|
| Receptors, Progesterone | 1 | 2010 | 109 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2010 | 111 | 0.080 |
Why?
|
| Crotalus | 1 | 2009 | 1 | 0.080 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 2009 | 3 | 0.080 |
Why?
|
| Alkalies | 1 | 2009 | 3 | 0.080 |
Why?
|
| Viper Venoms | 1 | 2009 | 2 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2011 | 297 | 0.080 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 101 | 0.080 |
Why?
|
| Acids | 1 | 2009 | 14 | 0.080 |
Why?
|
| Stereoisomerism | 1 | 2009 | 67 | 0.080 |
Why?
|
| Hydrolysis | 1 | 2009 | 142 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2011 | 338 | 0.080 |
Why?
|
| Catalysis | 1 | 2009 | 153 | 0.080 |
Why?
|
| Biophysical Phenomena | 1 | 2008 | 22 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 456 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 203 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 99 | 0.080 |
Why?
|
| Nucleotides | 1 | 2008 | 41 | 0.080 |
Why?
|
| Biophysics | 1 | 2008 | 43 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 420 | 0.070 |
Why?
|
| Research Design | 1 | 2011 | 581 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2021 | 588 | 0.070 |
Why?
|
| Introns | 2 | 2018 | 105 | 0.070 |
Why?
|
| Carbohydrate Conformation | 1 | 2007 | 15 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 761 | 0.060 |
Why?
|
| Glycosylation | 1 | 2006 | 133 | 0.060 |
Why?
|
| Cytidine | 1 | 2025 | 14 | 0.060 |
Why?
|
| APOBEC Deaminases | 1 | 2025 | 10 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 293 | 0.060 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.060 |
Why?
|
| Antagomirs | 1 | 2024 | 5 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2024 | 111 | 0.050 |
Why?
|
| Templates, Genetic | 1 | 2023 | 21 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 290 | 0.050 |
Why?
|
| APOBEC-3G Deaminase | 1 | 2022 | 21 | 0.050 |
Why?
|
| Neurons | 2 | 2021 | 865 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2023 | 38 | 0.050 |
Why?
|
| Biotinylation | 1 | 2022 | 38 | 0.050 |
Why?
|
| Dipeptides | 1 | 2022 | 61 | 0.050 |
Why?
|
| Exons | 1 | 2022 | 191 | 0.050 |
Why?
|
| Biotin | 1 | 2022 | 52 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2024 | 484 | 0.050 |
Why?
|
| K562 Cells | 1 | 2021 | 58 | 0.050 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2023 | 263 | 0.050 |
Why?
|
| Cell-Free System | 1 | 2021 | 31 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 357 | 0.050 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2021 | 20 | 0.050 |
Why?
|
| Surface Plasmon Resonance | 1 | 2021 | 33 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2022 | 244 | 0.050 |
Why?
|
| Serum Albumin, Bovine | 1 | 2021 | 34 | 0.050 |
Why?
|
| Muramidase | 1 | 2021 | 47 | 0.050 |
Why?
|
| Ribonucleoproteins | 1 | 2022 | 112 | 0.040 |
Why?
|
| G-Quadruplexes | 1 | 2020 | 6 | 0.040 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2020 | 27 | 0.040 |
Why?
|
| Goals | 1 | 2021 | 91 | 0.040 |
Why?
|
| Cell Line | 2 | 2018 | 2014 | 0.040 |
Why?
|
| Genome | 1 | 2022 | 257 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 114 | 0.040 |
Why?
|
| Mitosis | 1 | 2020 | 210 | 0.040 |
Why?
|
| Particle Size | 1 | 2020 | 400 | 0.040 |
Why?
|
| Escherichia coli Proteins | 1 | 2021 | 264 | 0.040 |
Why?
|
| DNA Replication | 1 | 2020 | 231 | 0.040 |
Why?
|
| Endothelium, Corneal | 1 | 2018 | 1 | 0.040 |
Why?
|
| Oligoribonucleotides, Antisense | 1 | 2018 | 2 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1226 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2018 | 109 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 76 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2018 | 457 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 92 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 3222 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 254 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1346 | 0.030 |
Why?
|
| Proteins | 1 | 2022 | 741 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2020 | 535 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 466 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 701 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 194 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2011 | 39 | 0.020 |
Why?
|
| Ataxin-3 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 90 | 0.020 |
Why?
|
| Transition Temperature | 1 | 2010 | 5 | 0.020 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2010 | 29 | 0.020 |
Why?
|
| Luciferases, Firefly | 1 | 2010 | 17 | 0.020 |
Why?
|
| Interferons | 1 | 2010 | 63 | 0.020 |
Why?
|
| RNA Stability | 1 | 2010 | 94 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2010 | 214 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 307 | 0.020 |
Why?
|
| Child | 1 | 2018 | 4380 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5289 | 0.020 |
Why?
|
| United States | 1 | 2021 | 7657 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1975 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 389 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 420 | 0.020 |
Why?
|
| Peptides | 1 | 2011 | 551 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 6041 | 0.020 |
Why?
|
| Female | 2 | 2018 | 31706 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1150 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 13873 | 0.010 |
Why?
|
| Middle Aged | 1 | 2018 | 16857 | 0.010 |
Why?
|
| Adult | 1 | 2018 | 16211 | 0.010 |
Why?
|